Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial Results
Tenon Medical (NASDAQ: TNON), a healthcare company focused on Sacroiliac Joint (SIJ) disorders, has scheduled its Q1 2025 financial results announcement for May 13, 2025, after market close. The company will host a conference call at 4:30 p.m. Eastern Time, featuring a Q&A session with covering analysts.
Investors can access the call through:
- US Dial-in: 1-877-407-0792
- International Dial-in: 1-201-689-8263
Participants are advised to dial in 10 minutes before the call starts. A replay will be available through May 28, 2025, via the company's IR website or by phone (US: 1-844-512-2921, International: 1-412-317-6671) using access code 13752970.
Tenon Medical (NASDAQ: TNON), un'azienda sanitaria specializzata nei disturbi dell'articolazione sacroiliaca (SIJ), ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per il 13 maggio 2025, dopo la chiusura dei mercati. La società terrà una conference call alle 16:30 ora Eastern, con una sessione di domande e risposte con gli analisti presenti.
Gli investitori possono accedere alla chiamata tramite:
- Numero USA: 1-877-407-0792
- Numero internazionale: 1-201-689-8263
Si consiglia ai partecipanti di collegarsi 10 minuti prima dell'inizio della chiamata. Una registrazione sarà disponibile fino al 28 maggio 2025, tramite il sito IR della società o telefonicamente (USA: 1-844-512-2921, Internazionale: 1-412-317-6671) utilizzando il codice di accesso 13752970.
Tenon Medical (NASDAQ: TNON), una empresa de salud centrada en trastornos de la articulación sacroilíaca (SIJ), ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el 13 de mayo de 2025, después del cierre del mercado. La compañía realizará una conferencia telefónica a las 4:30 p.m. hora del Este, con una sesión de preguntas y respuestas con analistas participantes.
Los inversores pueden acceder a la llamada a través de:
- Marcación en EE. UU.: 1-877-407-0792
- Marcación internacional: 1-201-689-8263
Se recomienda a los participantes marcar 10 minutos antes del inicio de la llamada. Una repetición estará disponible hasta el 28 de mayo de 2025, a través del sitio web de relaciones con inversores de la empresa o por teléfono (EE. UU.: 1-844-512-2921, Internacional: 1-412-317-6671) usando el código de acceso 13752970.
Tenon Medical (NASDAQ: TNON)은 천장관절(SIJ) 장애에 중점을 둔 헬스케어 회사로, 2025년 1분기 재무 결과 발표를 2025년 5월 13일 장 마감 후에 예정하고 있습니다. 회사는 동부 시간 기준 오후 4시 30분에 애널리스트들과 질의응답 세션이 포함된 컨퍼런스 콜을 진행할 예정입니다.
투자자들은 다음 번호로 전화하여 참여할 수 있습니다:
- 미국 전화: 1-877-407-0792
- 국제 전화: 1-201-689-8263
참가자들은 콜 시작 10분 전에 접속할 것을 권장합니다. 녹음 재청취는 2025년 5월 28일까지 회사 IR 웹사이트 또는 전화(미국: 1-844-512-2921, 국제: 1-412-317-6671)에서 접속 코드 13752970을 사용해 이용할 수 있습니다.
Tenon Medical (NASDAQ : TNON), une entreprise de santé spécialisée dans les troubles de l'articulation sacro-iliaque (SIJ), a programmé l'annonce de ses résultats financiers du premier trimestre 2025 pour le 13 mai 2025, après la clôture des marchés. La société organisera une conférence téléphonique à 16h30 heure de l'Est, incluant une session de questions-réponses avec les analystes présents.
Les investisseurs peuvent accéder à l'appel via :
- Numéro d'accès aux États-Unis : 1-877-407-0792
- Numéro d'accès international : 1-201-689-8263
Il est conseillé aux participants de se connecter 10 minutes avant le début de l'appel. Une rediffusion sera disponible jusqu'au 28 mai 2025, via le site web IR de la société ou par téléphone (États-Unis : 1-844-512-2921, International : 1-412-317-6671) en utilisant le code d'accès 13752970.
Tenon Medical (NASDAQ: TNON), ein Gesundheitsunternehmen, das sich auf Sakroiliakalgelenk (SIJ) Erkrankungen spezialisiert hat, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für den 13. Mai 2025 nach Börsenschluss geplant. Das Unternehmen wird um 16:30 Uhr Eastern Time eine Telefonkonferenz mit einer Fragerunde mit teilnehmenden Analysten veranstalten.
Investoren können die Telefonkonferenz über folgende Nummern erreichen:
- US-Einwahlnummer: 1-877-407-0792
- Internationale Einwahlnummer: 1-201-689-8263
Teilnehmer werden gebeten, sich 10 Minuten vor Beginn der Telefonkonferenz einzuwählen. Eine Aufzeichnung ist bis zum 28. Mai 2025 über die IR-Website des Unternehmens oder telefonisch (USA: 1-844-512-2921, international: 1-412-317-6671) unter Verwendung des Zugangscodes 13752970 verfügbar.
- Maintains NASDAQ listing and compliance through regular financial reporting
- Demonstrates transparency by hosting analyst Q&A session
- None.
LOS GATOS, CA / ACCESS Newswire / April 29, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced plans to release financial results for the first quarter 2025 ended March 31, 2025 after market close on Tuesday, May 13, 2025. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.
Date: |
| Tuesday, May 13, 2025 |
Time: |
| 4:30 p.m. Eastern time |
Dial-in: |
| 1-877-407-0792 |
International Dial-in: |
| 1-201-689-8263 |
Webcast: |
|
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
An audio playback of the call will be available through May 28, 2025, on Tenon's Investor Relations website at http://ir.tenonmed.com/ or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671 (International). The access code will be 13752970.
About Tenon Medical, Inc.
Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran™ Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022, Tenon is focused on three commercial opportunities with its System in the SI Joint market which includes: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants and 3) SI Joint fusion adjunct to a spine fusion construct. For more information, please visit www.tenonmed.com.
The Tenon Medical logo shown above, and Catamaran®, PiSIF®, CAT PiSIF®, ETAD®, Posterior Inferior Sacroiliac Fusion®, CAT SIJ Fusion System®, Catamaran SIJ Fusion System®, Catamaran Inferior Posterior Fusion System®, Catamaran Transfixation Fusion System®, and Catamaran Transfixation Fusion Device® are registered trademarks of Tenon Medical, Inc. MAINSAILTM is also a trademark of Tenon Medical, Inc.
Investor Contact
Shannon Devine
MZ North America
203-741-8811
tenon@mzgroup.us
SOURCE: Tenon Medical, Inc.
View the original press release on ACCESS Newswire
FAQ
When will Tenon Medical (TNON) release Q1 2025 earnings?
How can I join Tenon Medical's Q1 2025 earnings call?
Where can I listen to the replay of TNON's Q1 2025 earnings call?
What medical conditions does Tenon Medical (TNON) treat?
